cannabis indica

Índice completo — página 9 de 77

Estudos 801 a 900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2022. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 801 a 900

  1. 2022

    Cannabis Use among Patients with Alopecia Areata: A Cross-Sectional Survey Study

    FavorávelMetanáliseQueda de Cabelo
  2. 2022

    Cannabis use among patients with cutaneous lymphoma: A cross-sectional survey

    FavorávelMetanáliseCâncerCâncer — LinfomaPrurido
  3. 2022

    Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+4
  4. 2022

    Cannabis Use Among Young Adults in Washington State After Legalization of Nonmedical Cannabis

  5. 2022

    Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisPsicose
  6. 2022

    Cannabis Use and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

    DesfavorávelMetanáliseAVC
  7. 2022

    Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort

    InconclusivoMetanáliseEfeitos Adversos da CannabisPsicoseEsquizofrenia
  8. 2022

    Cannabis use and related clinical variables in patients with obsessive-compulsive disorder

    InconclusivoEnsaio ClínicoTOC
  9. 2022

    Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study

  10. 2022

    Cannabis use and social anxiety in young adulthood: A meta-analysis

    DesfavorávelMetanáliseDependência — CannabisAnsiedade
  11. 2022

    Cannabis use and subjective response to alcohol in the human laboratory

  12. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  13. 2022

    Cannabis use and the risk of periodontitis: A two-sample Mendelian randomization study

  14. 2022

    Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

  15. 2022

    Cannabis use as a moderator of cognitive behavioral therapy for insomnia

    InconclusivoEnsaio Clínico Duplo-CegoInsônia e Distúrbios do Sono
  16. 2022

    Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)

    FavorávelMetanáliseObesidadeSíndrome MetabólicaHIV/AIDS+1
  17. 2022

    Cannabis Use Disorder Is Associated With Longer In-Hospital Lengths of Stay, Higher Rates of Medical Complications, and Costs of Care Following Primary 1- to 2-Level Lumbar Fusion

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — Cannabis
  18. 2022

    Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand

    FavorávelMetanáliseEndometriose
  19. 2022

    Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

  20. 2022

    Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis

  21. 2022

    Cannabis use in Parkinson's disease-A nationwide online survey study

    FavorávelMetanáliseDoença de Parkinson
  22. 2022

    Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review

    FavorávelMetanáliseInsônia e Distúrbios do Sono
  23. 2022

    Cannabis Use is Associated with Prevalent Coronary Artery Disease

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoAterosclerose
  24. 2022

    Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)

  25. 2022

    Cannabis Vaping Among Youth and Young Adults: a Scoping Review

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  26. 2022

    Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology

  27. 2022

    Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents

    InconclusivoEstudo em AnimaisPsicoseEsquizofrenia
  28. 2022

    Cannabis with breast cancer treatment: propitious or pernicious?

    DesfavorávelEstudo LaboratorialCâncerCâncer — Mama
  29. 2022

    Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study

    FavorávelEnsaio Clínico Duplo-CegoEpilepsiaTetraidrocanabinol (THC)
  30. 2022

    Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series

  31. 2022

    Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain

    InconclusivoMetanáliseDorDor — Crônica
  32. 2022

    Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls

    FavorávelMetanáliseDorDor — CrônicaDor — Neuropatia Periférica+1
  33. 2022

    Cannabis-Based Products for Chronic Pain : A Systematic Review

  34. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+29
  35. 2022

    Cannabis-related allergies: An international overview and consensus recommendations

    FavorávelMetanáliseEfeitos Adversos da CannabisAlergia à Cannabis
  36. 2022

    Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

    FavorávelMetanáliseDorCâncerNáusea e Vômito+1
  37. 2022

    Capgras Syndrome Due to Cannabinoids Use: A Case Report With Radiological Findings

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadePsicose+2
  38. 2022

    Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing

  39. 2022

    Case report: A case of undiagnosed cannabinoid hyperemesis syndrome in rural part of Nepal

  40. 2022

    Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

  41. 2022

    Case report: Medical cannabis-warfarin drug-drug interaction

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  42. 2022

    Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis

    DesfavorávelMetanáliseDorDor — CrônicaSíndrome da Hiperêmese Canabinoide
  43. 2022

    Causal effects of cannabis legalization on parents, parenting, and children: A systematic review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  44. 2022

    CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice

  45. 2022

    CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review

  46. 2022

    CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines

  47. 2022

    Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder

    InconclusivoEstudo em AnimaisTDA e TDAHEndocanabinoide (não especificado)
  48. 2022

    Central stress response among deprived and continuing marijuana users and nonusers

    InconclusivoEnsaio Clínico
  49. 2022

    Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study

  50. 2022

    Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada

  51. 2022

    Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences

  52. 2022

    Characterization of the Biological Activity of the Ethanolic Extract from the Roots of Cannabis sativa L. Grown in Aeroponics

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoCicatrização
  53. 2022

    Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC)

    FavorávelEstudo LaboratorialGestação
  54. 2022

    Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+1
  55. 2022

    Chemical Analysis by LC-MS of Cannabis sativa Root Samples from Northeast Brazil and Evaluation of Antitussive and Expectorant Activities

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)
  56. 2022

    Chemical Composition, Enantiomeric Distribution and Anticholinesterase and Antioxidant Activity of the Essential Oil of Diplosthephium juniperinum

    FavorávelEstudo LaboratorialInflamaçãoEstresse Oxidativo
  57. 2022

    Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

  58. 2022

    Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice

    DesfavorávelEstudo em AnimaisCâncerCâncer — OvárioCanabinoides Sintéticos JWH-x
  59. 2022

    Chronic delta-9-tetrahydrocannabinol exposure impacts testicular volume and male reproductive health in rhesus macaques

    DesfavorávelEstudo em AnimaisGestação
  60. 2022

    Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function

    DesfavorávelEstudo em AnimaisDistúrbios de CoagulaçãoTetraidrocanabinol (THC)
  61. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+8
  62. 2022

    Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study

    DesfavorávelMetanáliseDiabetesGestaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  63. 2022

    Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort

    InconclusivoEnsaio ClínicoTEPTAnandamida (AEA)Endocanabinoide (não especificado)+2
  64. 2022

    Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

    FavorávelEnsaio ClínicoAnsiedadeDisfunção CognitivaInsônia e Distúrbios do Sono+1
  65. 2022

    Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders

    FavorávelMetanáliseAutismo
  66. 2022

    Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia

  67. 2022

    Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists

  68. 2022

    Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisPsicose+3
  69. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  70. 2022

    Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Proceduresv

  71. 2022

    Clinician responses to cannabis use during pregnancy and lactation: a systematic review and integrative mixed-methods research synthesis

    InconclusivoMetanáliseEfeitos Adversos da CannabisGestação
  72. 2022

    Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity

    FavorávelMetanáliseEfeitos Adversos da CannabisObesidade
  73. 2022

    Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

  74. 2022

    Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisPsicose
  75. 2022

    Cognitive functioning and cannabis use in first-episode psychosis

    InconclusivoMetanálisePsicose
  76. 2022

    Combination of 1,8-cineole and beta-caryophyllene synergistically reverses cardiac hypertrophy in isoprenaline-induced mice and H9c2 cells

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  77. 2022

    Combinatorial Antimicrobial Efficacy and Mechanism of Linalool Against Clinically Relevant Klebsiella pneumoniae

    FavorávelEstudo LaboratorialEstresse OxidativoInfecções Bacterianas
  78. 2022

    Common and distinguishing genetic factors for substance use behavior and disorder: an integrated analysis of genomic and transcriptomic studies from both human and animal studies

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+4
  79. 2022

    Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaEfeitos Adversos da Cannabis
  80. 2022

    Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis

  81. 2022

    Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults With Neuropathic Pain After Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials

    InconclusivoMetanálise ClínicaDorInsônia e Distúrbios do SonoDor — Neuropatia Periférica+2
  82. 2022

    Comparative light and scanning electron microscopic studies of pollen of two marijuana species causing allergies

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisNáusea e VômitoAlergia à Cannabis
  83. 2022

    Comparative Pharmacokinetics of Δ 9-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats

    InconclusivoEstudo em AnimaisEfeitos Adversos da Cannabis
  84. 2022

    Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças de PeleTetraidrocanabinol (THC)
  85. 2022

    Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice

    FavorávelEstudo em AnimaisTEPT
  86. 2022

    Comparison of bacterial disinfection efficacy using blue and red lights on dental implants contaminated with Aggregatibacter actinomycetemcomitans

    FavorávelEstudo LaboratorialInfecções BacterianasDoença PeriodontalFicocianina
  87. 2022

    Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

    FavorávelMetanáliseDorDor — CrônicaTHC FarmacêuticoTHC:CBD Farmacêutico
  88. 2022

    Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities

    DesfavorávelMetanáliseCOVID-19
  89. 2022

    Consumer Perspectives on and Utilization of Medical Cannabis to Treat Dermatologic Conditions

    FavorávelMetanáliseInflamaçãoAcnePsoríase
  90. 2022

    Controlled Trial Examining the Strength-Based Grit Wellbeing and Self-Regulation Program for Young People in Residential Settings for Substance Use

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+4
  91. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+18
  92. 2022

    Correlates of high phosphatidylethanol (PEth) levels and their concordance with self-reported heavy alcohol consumption among men who have sex with men who binge drink alcohol

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — Álcool
  93. 2022

    Correlates of the nicotine metabolite ratio in Alaska Native people who smoke cigarettes

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+1
  94. 2022

    Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

  95. 2022

    Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications

    DesfavorávelMetanáliseTetraidrocanabinol (THC)
  96. 2022

    Cost-Effectiveness of Motivational Interviewing to Reduce Alcohol and Cannabis Use Among Patients With Depression

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+1
  97. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  98. 2022

    Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence

  99. 2022

    Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors

    FavorávelEstudo em AnimaisDiabetesCúrcuma
  100. 2022

    Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents